See more : PT Solusi Sinergi Digital Tbk (WIFI.JK) Income Statement Analysis – Financial Results
Complete financial analysis of Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Shanghai Kaibao Pharmaceutical CO.,Ltd, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Spirit AeroSystems Holdings, Inc. (SPR) Income Statement Analysis – Financial Results
- IS DongSeo Co., Ltd. (010780.KS) Income Statement Analysis – Financial Results
- Legato Merger Corp. (LEGO) Income Statement Analysis – Financial Results
- R&B Food Supply Public Company Limited (RBF.BK) Income Statement Analysis – Financial Results
- FinVolution Group (FINV) Income Statement Analysis – Financial Results
Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ)
About Shanghai Kaibao Pharmaceutical CO.,Ltd
Shanghai Kaibao Pharmaceutical CO.,Ltd engages in the research, development, production, and sale of modern Chinese medicines primarily in China. Its primary products include Tanreqing injection for the treatment of pneumonia, acute and chronic bronchitis, and upper respiratory tract infection; Tanreqing capsules that clears heat and detoxifies and removes phlegm; tiopronin for injection, which improves liver function of various acute and chronic hepatitis; Tiopronin enteric-coated tablets for adjuvant treatment of chronic hepatitis; and Xiongdan dropping pills that clears heat, calms liver, and improves eyesight. The company was founded in 2000 and is based in Shanghai, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.59B | 1.12B | 1.10B | 908.01M | 1.42B | 1.50B | 1.57B | 1.50B | 1.40B | 1.48B | 1.32B | 1.10B | 819.97M | 603.41M | 458.89M | 387.39M | 258.05M | 166.45M |
| Cost of Revenue | 311.82M | 247.57M | 234.92M | 179.85M | 251.21M | 263.65M | 291.83M | 280.74M | 250.36M | 230.00M | 204.37M | 178.68M | 149.01M | 107.53M | 78.29M | 69.60M | 45.73M | 27.56M |
| Gross Profit | 1.28B | 871.28M | 865.66M | 728.16M | 1.17B | 1.24B | 1.28B | 1.22B | 1.15B | 1.25B | 1.12B | 923.32M | 670.95M | 495.88M | 380.60M | 317.78M | 212.33M | 138.90M |
| Gross Profit Ratio | 80.44% | 77.87% | 78.65% | 80.19% | 82.30% | 82.43% | 81.41% | 81.25% | 82.06% | 84.47% | 84.56% | 83.79% | 81.83% | 82.18% | 82.94% | 82.03% | 82.28% | 83.44% |
| Research & Development | 95.87M | 52.97M | 79.32M | 59.12M | 54.56M | 47.35M | 64.69M | 48.20M | 49.54M | 56.93M | 49.47M | 39.73M | 29.07M | 22.21M | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 43.37M | 17.62M | 20.92M | 30.91M | 33.90M | 62.31M | 48.41M | 48.19M | 49.09M | 48.53M | 44.12M | 34.04M | 19.92M | 16.81M | 46.51M | 27.21M | 17.37M | 17.43M |
| Selling & Marketing | 777.07M | 555.87M | 594.77M | 515.77M | 747.65M | 773.51M | 800.58M | 747.39M | 681.57M | 715.56M | 660.09M | 569.55M | 432.40M | 320.46M | 262.95M | 224.80M | 150.35M | 100.69M |
| SG&A | 820.44M | 573.49M | 615.69M | 546.68M | 781.55M | 835.82M | 848.99M | 795.58M | 730.66M | 764.09M | 704.21M | 603.59M | 452.32M | 337.27M | 309.46M | 252.01M | 167.73M | 118.12M |
| Other Expenses | -17.03M | 1.93M | 8.69M | -1.76M | -634.05K | -226.90K | -5.17M | 8.23M | 6.90M | -18.99M | -1.86M | -3.52M | 15.73M | 2.43M | 14.52M | 8.62M | 10.31M | 4.42M |
| Operating Expenses | 899.28M | 666.85M | 732.46M | 633.37M | 884.38M | 931.37M | 964.61M | 900.93M | 843.51M | 858.91M | 785.62M | 679.60M | 507.53M | 378.72M | 312.62M | 254.76M | 169.57M | 119.31M |
| Cost & Expenses | 1.21B | 914.42M | 967.38M | 813.22M | 1.14B | 1.20B | 1.26B | 1.18B | 1.09B | 1.09B | 989.99M | 858.28M | 656.55M | 486.25M | 390.91M | 324.36M | 215.29M | 146.87M |
| Interest Income | 49.60M | 42.66M | 40.34M | 39.59M | 20.40M | 11.76M | 13.20M | 20.77M | 30.27M | 24.07M | 25.11M | 23.19M | 20.20M | 16.04M | 138.95K | 162.57K | -0.28 | -0.74 |
| Interest Expense | 118.55K | 127.32K | 148.50K | 515.97K | 151.10K | 120.78K | 108.35K | 191.27K | 2.24M | 20.76M | 121.35K | 96.87K | 43.28K | 362.23K | 3.14M | 1.93M | 843.85K | 687.67K |
| Depreciation & Amortization | 37.53M | 31.72M | 33.86M | 41.02M | 48.34M | 48.10M | 49.04M | 47.34M | 51.00M | 38.07M | 29.54M | 27.46M | 21.81M | 12.89M | 5.56M | 4.83M | 4.06M | 3.44M |
| EBITDA | 367.54M | 257.90M | 203.66M | 172.93M | 349.29M | 326.33M | 381.44M | 381.24M | 388.27M | 452.94M | 362.77M | 313.65M | 220.02M | 160.18M | 88.93M | 75.21M | 46.82M | 23.03M |
| EBITDA Ratio | 23.06% | 24.61% | 19.99% | 20.27% | 25.70% | 25.24% | 23.85% | 25.58% | 28.19% | 29.47% | 27.73% | 24.63% | 27.20% | 27.20% | 19.21% | 19.77% | 18.96% | 14.45% |
| Operating Income | 382.96M | 228.37M | 171.83M | 134.42M | 301.84M | 274.93M | 332.61M | 325.10M | 327.91M | 409.90M | 354.01M | 266.59M | 182.48M | 129.24M | 65.72M | 59.82M | 39.81M | 17.87M |
| Operating Income Ratio | 24.02% | 20.41% | 15.61% | 14.80% | 21.27% | 18.32% | 21.19% | 21.71% | 23.49% | 27.68% | 26.75% | 24.19% | 22.25% | 21.42% | 14.32% | 15.44% | 15.43% | 10.74% |
| Total Other Income/Expenses | 574.75K | -2.18M | -2.18M | -2.81M | -634.05K | -226.90K | -5.17M | 8.13M | 6.90M | 7.55M | 23.13M | 19.58M | 15.73M | 18.06M | 14.52M | 8.62M | 10.31M | 4.42M |
| Income Before Tax | 383.53M | 226.19M | 169.65M | 131.60M | 301.21M | 274.71M | 327.44M | 333.23M | 334.82M | 414.84M | 377.14M | 286.17M | 198.21M | 147.30M | 80.24M | 68.44M | 50.13M | 22.30M |
| Income Before Tax Ratio | 24.06% | 20.22% | 15.41% | 14.49% | 21.23% | 18.31% | 20.86% | 22.26% | 23.99% | 28.01% | 28.50% | 25.97% | 24.17% | 24.41% | 17.48% | 17.67% | 19.43% | 13.39% |
| Income Tax Expense | 56.63M | 36.11M | 29.54M | 25.48M | 50.22M | 47.89M | 55.14M | 50.63M | 53.17M | 65.49M | 58.32M | 43.98M | 30.65M | 23.60M | 11.57M | 10.79M | 5.32M | 1.43M |
| Net Income | 327.87M | 190.80M | 140.11M | 106.12M | 250.99M | 226.81M | 272.30M | 282.61M | 281.65M | 349.35M | 318.82M | 242.19M | 167.56M | 123.70M | 68.67M | 57.65M | 44.81M | 20.87M |
| Net Income Ratio | 20.57% | 17.05% | 12.73% | 11.69% | 17.69% | 15.11% | 17.35% | 18.88% | 20.18% | 23.59% | 24.09% | 21.98% | 20.44% | 20.50% | 14.96% | 14.88% | 17.36% | 12.54% |
| EPS | 0.31 | 0.18 | 0.13 | 0.10 | 0.24 | 0.21 | 0.25 | 0.26 | 0.26 | 0.33 | 0.30 | 0.23 | 0.16 | 0.12 | 0.09 | 0.07 | 0.38 | 0.18 |
| EPS Diluted | 0.31 | 0.18 | 0.13 | 0.10 | 0.24 | 0.21 | 0.25 | 0.26 | 0.26 | 0.33 | 0.30 | 0.23 | 0.16 | 0.12 | 0.09 | 0.07 | 0.38 | 0.18 |
| Weighted Avg Shares Out | 1.05B | 1.05B | 1.05B | 1.05B | 1.05B | 1.06B | 1.07B | 1.07B | 1.08B | 1.07B | 1.07B | 1.07B | 1.06B | 1.07B | 803.42M | 801.76M | 116.95M | 116.74M |
| Weighted Avg Shares Out (Dil) | 1.05B | 1.05B | 1.05B | 1.05B | 1.05B | 1.06B | 1.07B | 1.07B | 1.08B | 1.07B | 1.07B | 1.07B | 1.06B | 1.07B | 803.42M | 801.76M | 116.95M | 116.74M |
Source: https://incomestatements.info
Category: Stock Reports